Nephrotic Syndrome Steroid Sparing Agents Overview
Steroid sparing agents are medications used to reduce the required dosage or duration of corticosteroid therapy in treating nephrotic syndrome, aiming to minimize steroid-related side effects. The question asks to identify which drug among the options is NOT typically used for this purpose in children.
Drug Roles in Nephrotic Syndrome Treatment
- Levamisole: Can be used as a steroid sparing agent, particularly in frequently relapsing or steroid-dependent nephrotic syndrome.
- Cyclophosphamide: A common alkylating agent used as a steroid sparing agent to induce remission and reduce relapses.
- Mycophenolate mofetil: An immunosuppressant that serves as an alternative steroid sparing agent, especially when other options are contraindicated or ineffective.
- Aspirin: Primarily used for its antiplatelet effects to manage potential thromboembolic complications associated with nephrotic syndrome, not as a primary steroid sparing agent.
Identifying the Exception
Based on their established roles in managing childhood nephrotic syndrome:
- Levamisole, Cyclophosphamide, and Mycophenolate mofetil are recognized steroid sparing agents.
- Aspirin's primary role is prophylaxis or treatment of thrombosis, not reducing steroid dependence.
Therefore, Aspirin is the exception.